Change and Correlated Factors of Fasting Level of the Plasma Endotoxin in Subjects with Different Glucose Tolerances and Body Mass Indices

LIU Yun-hui, ZHAO Tie-yun, HOU Li-qiong

Abstract

To investigate the change of the levels of fasting plasma endotoxin (ET) and assess its correlated factors in individuals with different glucose tolerances and body mass indices. Methods The levels of fasting plasma ET were assayed by the endpoint chromogenic limulus amebocyte lysate method in subjects with type 2 diabetes (T2DM), impaired glucose regulation (IGR) and normal glucose tolerance (NGT). The height, body mass, waist, hips, systolic blood pressure and diastolic blood pressure were measured with the conventional methods; body mass index (BMI) and waist hip ratio (WHR) were calculated. All groups were divided into obesity (BMI ≥ 25 kg/m2) and non-obesity (BMI<25 kg/m2) subgroups. The levels of fasting blood glucose (FBG), 2 hours plasma glucose (2 hPG), fasting insulin (FINS), postprandial insulin (PINS), hemoglobin A1c (HbA1c), blood lipids, free fatty acids (FFA), serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were also analyzed, and homeostasis model assessment of insulin resistance (HOMA-IR) was calculated. The relationship of the levels of plasma ET with age, BMI, WHR, blood pressure, FBG, 2 hPG, FINS, PINS, HOMA-IR, HbA1c, blood lipids, FFA, AST and ALT were also analyzed. Results ①The levels of plasma ET in T2DM group (n=37) was significantly higher than that in NGT group (n=37)[7.1 (3.7-11.8) EU/mL vs. 4.5 (2.2-6.3) EU/mL, P<0.05]. The levels of plasma ET in IGR group (n=23)[5.0 (2.4-10.3) EU/mL] was lower than that in T2DM group and higher than NGT group but the differences were not significant (P>0.05). ② The levels of plasma ET in the obesity T2DM subgroup was higher than that in the non-obesity T2DM subgroup but the differences were not significant[7.3 (3.8-13.3) EU/mL vs. 7.0 (3.6-10.4) EU/mL, P>0.05].There was a remarkable difference in the levels of plasma ET between obesity and non-obesity subgroup of IGR[6.8(2.9-13.2) EU/mL vs. 2.7 (1.6-5.5) EU/mL, P<0.05], similarly between obesity and non-obesity subgroup of NGT[6.2 (3.4-12.7) EU/mL vs. 2.8 (1.8-4.9) EU/mL, P<0.05].③ Multiple linear regression analysis demonstrated that ET wasn't the important factor influencing FBG and 2 hPG.But BMI and FBG were the important factors influencing ET. 2 hPG and WHR weren't the important factors influencing ET. Conclusion With the increase in glucose metabolic abnormalities and BMI, the levels of plasma ET are gradually increased. ET isn't the important factor influencing FBG and 2 hPG. BMI and FBG are the important factors in influencing ET.

 

Keywords: Impaired glucose regulation, Diabetes, Plasma endotoxin

 

Full Text:

PDF


References


Jia W. Li H. Zhao L, et al. Gut microhiota; a potential new territory for drug targeting. Nat Rev Drug Discov,2008;7(2): 123-129.

Sanz Y. Santacruz A. Gauffin P. Gut microbiota in obesity and metabolic disorders. P Nutr Soc, 2010;69(3);434-41.

Ley RE. Backbed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA, 2005; 102 ( 31); 11070-11075.

De La Serre CB, Ellis CL, Lee J, et al. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol,2010; 299(2); G440-G448.

Lakhan SE. Kirchgessner A. Gut microbiota ang sirtuins in obesity related inflammation and bowel dysfunction. J Transl Med, 2011; 9 : 202. http;//www. translational-medicine. com/ content/9/1/202.

Harte AL, Varma MC, Tripathi G, et al. High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care,2012; 35(2);375-382.

Park SG, Kim JH,Oh JH,et al. Polymyxin В scavenger of endotoxin, enhances isolation yield and in vivo function of islets. Transpl Int,2010;23(3) ;325-332.

Amyot J, Semache M, Ferdaoussi M. et al. Lipopolysaccharides impair insulin gene expression in isolated islets of Langerhans via toll-like receptor-4 and NF-,cB signaling. PLoS ()NE,2012;7(4) ;e36200.

Mehta NN, Mcgillicuddy FC, Anderson PD, et al. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes,2010;59( 1) : 172-181. Pilon G, Charbonneau

Endotoxin mediated-iNOS inductin causes insulin resistance resistance via ONOO induced tyrosine nitration of IRS-1 in skeletal muscle. PLoS ()NE,2010;5( 12) ;el5912.

Monte SV, Caruana JA, Ghanim H, et al. Reduction in endotoxemia oxidative and inflammatory stess, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery, 2012;151(4);587-593.

Dixon AN, Valsamakis G, Hanif MW, et al. Effect of the orlistat on serum endotoxin lipopolysaccharide and adipocytokines in South Asian individual with impaired glucose tolerance. Int J Clin Pract,2008;62(7); 1124-1129.

Al-Attas OS, Al-Daghri NM, Al-Rubeaan K, et al. Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc Diabetol, 2009; 8: 20. http://www. cardiab. com/ content/8/1/20.

Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature,2009;457(7228); 480-484.

Million M, Maraninchi M, Henry M, et al. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacler smilhii. Int J Obes ( Lond) .2012;36(6);817-825.

Larsen N, Vogensen FK. Van den Berg FW. et al. Gut microbiota in human adualts with type 2 diabetes differs from non-diabetec adults. PLoS ONE.2010;5(2) :e9085.

Cani PD. Possemiers S, Van de Wiele, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut,2009;58(8): 1091-1103.


Refbacks

  • There are currently no refbacks.